• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振对动脉粥样硬化血栓形成的特征分析及分子检测——用于个体风险评估和诊断的潜在工具

Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.

作者信息

Ala-Korpela Mika, Sipola Petri, Kaski Kimmo

机构信息

Laboratory of Computational Engineering, Systems Biology and Bioinformation Technology, Helsinki University of Technology, Finland.

出版信息

Ann Med. 2006;38(5):322-36. doi: 10.1080/07853890600862418.

DOI:10.1080/07853890600862418
PMID:16938802
Abstract

This review focuses on recent non-invasive or minimally invasive magnetic resonance (MR) approaches to study atherothrombosis. The potential benefits of combining diverse metabolic information obtained by the variety of MR techniques from tissues in vivo and ex vivo and from body fluids in vitro are also briefly discussed. A well established methodology is available for lipoprotein subclass quantification from plasma by 1H MR spectroscopy providing information for assessing the long-term risk of atherosclerosis. Multi-contrast MR imaging in vivo relying on endogenous contrast allows partial characterization of components in atherothrombotic plaques. The use of exogenous contrast agents in MR angiography enhances blood-tissue contrast and provides functional information on plaque metabolism, improving plaque characterization and assessment of plaque vulnerability by MR imaging. Recent applications of molecular targeted MR imaging have revealed novel opportunities for specific early detection of atherothrombotic processes, such as angiogenesis and accumulation of macrophages. Currently, MR imaging and spectroscopy can produce such metabolic in vivo and in vitro information that in combination could facilitate the screening, identification and follow-up of cardiovascularly vulnerable patients in research settings. The recent developments imply that in the near future MR techniques will be part of clinical protocols for individual diagnostics in atherothrombosis.

摘要

本综述聚焦于近期用于研究动脉粥样硬化血栓形成的非侵入性或微创磁共振(MR)方法。还简要讨论了将通过多种MR技术从体内和体外组织以及体外体液获得的各种代谢信息相结合的潜在益处。有一种成熟的方法可通过1H MR光谱对血浆中的脂蛋白亚类进行定量,从而为评估动脉粥样硬化的长期风险提供信息。体内基于内源性对比剂的多对比MR成像能够部分表征动脉粥样硬化血栓斑块中的成分。MR血管造影中使用外源性对比剂可增强血液与组织的对比,并提供有关斑块代谢的功能信息,通过MR成像改善斑块表征和斑块易损性评估。分子靶向MR成像的近期应用揭示了早期特异性检测动脉粥样硬化血栓形成过程(如血管生成和巨噬细胞聚集)的新机会。目前,MR成像和光谱能够生成这样的体内和体外代谢信息,这些信息相结合可在研究环境中促进对心血管易损患者的筛查、识别和随访。近期的进展表明,在不久的将来,MR技术将成为动脉粥样硬化血栓形成个体诊断临床方案的一部分。

相似文献

1
Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.磁共振对动脉粥样硬化血栓形成的特征分析及分子检测——用于个体风险评估和诊断的潜在工具
Ann Med. 2006;38(5):322-36. doi: 10.1080/07853890600862418.
2
Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.易损动脉粥样硬化斑块的磁共振成像:当前成像策略与分子成像探针
J Magn Reson Imaging. 2007 Sep;26(3):460-79. doi: 10.1002/jmri.20989.
3
Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.使用新型α(nu)β3靶向纳米颗粒和1.5特斯拉磁共振成像对新生VX-2兔肿瘤中的血管生成进行分子成像。
Cancer Res. 2003 Sep 15;63(18):5838-43.
4
Molecular imaging by cardiovascular MR.心血管磁共振分子成像
J Cardiovasc Magn Reson. 2007;9(6):827-43. doi: 10.1080/10976640701693766.
5
Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.动态对比增强磁共振成像(DCE-MRI)在动脉粥样硬化斑块新生血管成像中的应用。
Angiogenesis. 2010 Jun;13(2):87-99. doi: 10.1007/s10456-010-9172-2. Epub 2010 Jun 6.
6
Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques.磁共振成像及血管内磁共振成像在检测易损斑块中的作用
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C48-56. doi: 10.1016/j.jacc.2005.11.048.
7
Cardiovascular molecular imaging: an overview.心血管分子成像:综述
Cardiovasc Res. 2009 Sep 1;83(4):643-52. doi: 10.1093/cvr/cvp209. Epub 2009 Jun 24.
8
Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis.磁共振分子成像造影剂及其在动脉粥样硬化中的应用。
Top Magn Reson Imaging. 2007 Oct;18(5):409-17. doi: 10.1097/rmr.0b013e31815a0e7f.
9
Magnetic resonance imaging and spectroscopy methods for molecular imaging.用于分子成像的磁共振成像和光谱学方法。
Q J Nucl Med Mol Imaging. 2009 Dec;53(6):565-85.
10
Cardiovascular molecular MR imaging.心血管分子磁共振成像
Eur J Nucl Med Mol Imaging. 2007 Jun;34 Suppl 1(Suppl 1):S99-104. doi: 10.1007/s00259-007-0444-z.

引用本文的文献

1
Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.用于血管和心脏疾病的纳米颗粒作为磁共振成像造影剂
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Mar-Apr;3(2):146-161. doi: 10.1002/wnan.114. Epub 2010 Oct 21.
2
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.4197例1型糖尿病患者的代谢表型、血管并发症及过早死亡情况
Diabetes. 2008 Sep;57(9):2480-7. doi: 10.2337/db08-0332. Epub 2008 Jun 10.
3
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death.
用于糖尿病并发症和过早死亡疾病连续体研究的1H核磁共振代谢组学方法
Mol Syst Biol. 2008;4:167. doi: 10.1038/msb4100205. Epub 2008 Feb 12.
4
A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data.一种用于量化临床变量并在1H NMR代谢组学数据中确定其光谱对应物的新型贝叶斯方法。
BMC Bioinformatics. 2007 May 3;8 Suppl 2(Suppl 2):S8. doi: 10.1186/1471-2105-8-S2-S8.